Sana Biotechnology (SANA) Stock Statistics & Valuation Metrics

Sana Biotechnology has a market cap or net worth of $1.07B. The enterprise value is $837.53M.

Sana Biotechnology has 278,291,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sana Biotechnology’s return on equity (ROE) is -1.52 and return on invested capital (ROIC) is -54.08%.

The current PE Ratio of Sana Biotechnology is ―. Sana Biotechnology’s PEG ratio is 0.25.

In the last 12 months, Sana Biotechnology had revenue of 0.00 and earned -244.17M in profits. Earnings per share was -0.96.

In the last 12 months, operating cash flow was -132.55M and capital expenditures -1.09M, giving a free cash flow of -133.64M billion.

Sana Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Sana Biotechnology upcoming earnings date is Jul 30, 2026, After Close (Confirmed).

Sana Biotechnology as a current ratio of 1.89, with Debt / Equity ratio of 63.17%

In the past 12 months, Sana Biotechnology has paid 0.00 in taxes.

Sana Biotechnology EV to EBITDA ratio is -4.48, with an EV/FCF ratio of -7.17.

Sana Biotechnology has $101.14M in cash and marketable securities with $75.33M in debt, giving a net cash position of $25.81M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sana Biotechnology is $9.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy